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Abstract
Normalization is an essential step with considerable impact on high-throughput RNA
sequencing (RNA-seq) data analysis. Although there are numerous methods for read count
normalization, it remains a challenge to choose an optimal method due to multiple factors
contributing to read count variability that affects the overall sensitivity and specificity. In
order to properly determine the most appropriate normalization methods, it is critical to com-
pare the performance and shortcomings of a representative set of normalization routines
based on different dataset characteristics. Therefore, we set out to evaluate the perfor-
mance of the commonly used methods (DESeq, TMM-edgeR, FPKM-CuffDiff, TC, Med UQ
and FQ) and two new methods we propose: Med-pgQ2 and UQ-pgQ2 (per-gene normaliza-
tion after per-sample median or upper-quartile global scaling). Our per-gene normalization
approach allows for comparisons between conditions based on similar count levels. Using
the benchmark Microarray Quality Control Project (MAQC) and simulated datasets, we per-
formed differential gene expression analysis to evaluate these methods. When evaluating
MAQC2 with two replicates, we observed that Med-pgQ2 and UQ-pgQ2 achieved a slightly
higher area under the Receiver Operating Characteristic Curve (AUC), a specificity rate >
85%, the detection power > 92% and an actual false discovery rate (FDR) under 0.06 given
the nominal FDR (0.05). Although the top commonly used methods (DESeq and TMM-
edgeR) yield a higher power (>93%) for MAQC2 data, they trade off with a reduced specific-
ity (<70%) and a slightly higher actual FDR than our proposed methods. In addition, the
results from an analysis based on the qualitative characteristics of sample distribution for
MAQC2 and human breast cancer datasets show that only our gene-wise normalization
methods corrected data skewed towards lower read counts. However, when we evaluated
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MAQC3 with less variation in five replicates, all methods performed similarly. Thus, our pro-
posed Med-pgQ2 and UQ-pgQ2 methods perform slightly better for differential gene analy-
sis of RNA-seq data skewed towards lowly expressed read counts with high variation by
improving specificity while maintaining a good detection power with a control of the nominal
FDR level.
Introduction
High-throughput RNA sequencing (RNA-seq) has become the preferred choice for gene
expression studies due to technological advances allowing for increased transcriptome cover-
age and reduced cost. These improvements have enabled studies with a large range of applica-
tions including identification of alternative splicing isoforms [1–3], de novo transcript
assembly to identify novel genes and isoforms [4–6], detection of single-nucleotide polymor-
phisms (SNPs) [7,8] and novel single nucleotide variants (SNVs) [9], and characterization of
mRNA editing [10]. In addition, RNA-seq enables the detection of rare transcripts while allow-
ing for high coverage of the genome, which cannot be identified as well by microarray technol-
ogies [11]. However, the most common and popular application of RNA-seq experiments is
the identification of differentially expressed genes (DEGs) between two or more conditions.
These DEGs may serve as biomarkers for clinical diagnosis, with possible implications for pre-
vention, prognosis and treatment [12,13].
Currently, several sequencing platforms exist, which require similar sample pre-processing
and subsequent analytical steps, as summarized by Zhang et al. [14]. Briefly, this RNA-seq
workflow consists of three major steps: 1) RNA-seq library construction; 2) sequencing and
mapping; and 3) normalization and statistical modeling to identify the DEGs or transcript iso-
forms. Following the second step, raw mapped reads generated by an aligner such as TopHat2
[15] are further normalized by a variety of methods, which generally include within-sample
and between-sample normalization. Normalization is a crucial step in gene expression studies
for both microarray and RNA-seq data [16–19].
In RNA-seq, the expression level of each mRNA transcript is measured by the total number
of mapped fragmented transcripts, which is expected to directly correlate with its abundance
level. The expected expression level of each transcript is limited by the sequencing depth or
total number of reads, which is pre-determined by the experimental design and budget before
sequencing. Since the expression level of the transcripts within the sample is dependent upon
the other transcripts present [20], given a fixed total read count, higher expressed transcripts
will have a greater proportion of total reads [19,21]. Furthermore, longer transcripts have
more reads mapping to them compared with shorter transcripts of a similar expression level
[22]. Therefore, a number of normalization methods for RNA-seq data have been proposed to
correct for library size bias as well as length and GC-content bias. These methods include per-
sample Total Counts (TC) implemented in EDASeq [23,24], per-sample Upper Quartile (UQ)
implemented in edgeR, Cufflink-Cuffdiff2 and EDASeq [18,24–26], per-sample Median (Med)
implemented in EDASeq [23,24], DESeq normalization (median-of-ratios) implemented in
DESeq and DESeq2 [27,28], Trimmed Mean of M values (TMM) implemented in edgeR [19],
Full Quantile (FQ) implemented in Aroma.light [29,30], Reads Per Kilobase per Million
mapped reads (RPKM) [21] and Fragments Per Kilobase per Million mapped fragments
(FPKM) implemented in Cufflinks-CuffDiff and Cufflinks-CuffDiff2 [26,31,32], normalization
by control genes [18,33] and normalization by GC-content [24]. To correct for library size,
RNA-seq normalization methods
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most of these methods, including TC, UQ, Med, DESeq and TMM, use a common scaling fac-
tor per sample to normalize genes. Among these, UQ, Med, FQ and control gene normaliza-
tion are techniques previously employed in microarray analysis.
Given the variety of read count normalization methods for RNA-seq analysis, it can be chal-
lenging for scientists to determine which method is optimal with regards to sensitivity and
specificity due to a variety of factors such as read depth, biological variation and the number of
biological replicates in the RNA-seq data. Previous studies comparing these methods for DEG
analysis suggested the use of DESeq and TMM-edgeR packages based on the false positive rate
and detection power [18,20,23,34–36]. However, while DESeq and TMM-edgeR were reported
to have overall better performance, these studies also report the false discovery rate (FDR) was
higher than the nominal FDR, leading to an inflated type I error rate. Therefore, in this study,
we explore new normalization methods and find a slight improvement over the existing meth-
ods with the dual goals of maintaining a nominal FDR level and a good specificity rate.
RNA-seq data are obtained from complex experiments with a variety of technical variations
across different conditions and adjustments made for read depth and other variation [33]. For
example, the mean read counts of genes can range from less than one reads for lowly abundant
genes to thousands or millions of reads for highly abundant genes. In order to correct for the
variation of each gene across samples or conditions, we propose a two-step normalization pro-
cedure: correcting the read depth through quantile normalization per sample followed by per
gene and per 100 reads normalization across samples. This idea is adapted from the normaliza-
tion of one-color cDNA microarray and RPKM and FPKM in RNA-seq [16,17,21,31]. The
reads of each gene per sample are scaled by Med or UQ normalization. Then, the Med or UQ-
normalized reads of each gene per sample are further scaled by the median per 100 reads
across conditions. Thus, the reads in each gene are similarly scaled, allowing for an accurate
comparison of gene expression across conditions.
In this study, we evaluated our methods (Med-pgQ2 and UQ-pgQ2) along with the public
available methods. We used the exact test with a negative binomial distribution from edgeR to
identify DEGs for the normalization methods including TC, Med, UQ, FQ and our two pro-
posed methods. We used DESeq2 for DESeq normalization and Cufflinks-Cuffdiff2 for FPKM
normalization to test DEGs. The benchmark Microarray Quality Control Project (MAQC2
and MAQC3) datasets, simulated data and real human breast cancer RNA-seq data with a vari-
ety of properties were used to compare these methods.
Materials and methods
Normalization methods
Within-sample and between-sample normalization methods. Within-sample normali-
zation enables the correction of expression level in each gene associated with other genes in
the same sample. Since a long gene or transcript has more reads mapping to it compared to a
short gene or transcript with a similar expression, length normalization is taken into consider-
ation in some normalization methods. Currently, the most widely used methods, including
both within-sample and between-sample normalization, are RPKM [21] and FPKM [31].
FPKM is used to count the reads of a fragment for paired-end RNA-seq data, which produces
two mapped reads. However, the correction for the difference in gene length for analysis of
DEGs could introduce a bias in per-gene variance especially for low abundance genes [22,23].
Within-sample normalization methods. Since the prominent variation of read counts
for a gene between samples is due to differences in library size or sequencing depth, within-
sample normalization of raw reads is critical for the comparison of these gene expression mea-
sures across experimental conditions. The simplest normalization method is TC
RNA-seq normalization methods
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normalization, which adjusts the raw reads of each transcript by the total library size per sam-
ple. However, the comparison of RNA-seq normalization methods shows that Med, UQ,
TMM from edgeR, DESeq and FQ normalization methods are much better than TC [23]. One
reason is that a small number of highly expressed genes can consume a significant amount of
the total sequence [18]. To account for this feature, scaling factors are estimated from the data
and are used to achieve within-sample normalization [18,23].
Med-pgQ2 and UQ-pgQ2 normalization methods that we propose. Since the variation
among genes within a sample and the variation per-gene across samples due to the systemati-
cal bias need to be corrected in order to accurately identify DEGs between conditions, we pro-
pose two-step per-gene normalization methods called Med-pgQ2 and UQ-pgQ2.
In the following, we define statistical notations for characterizing different normalization
techniques. For simplicity, we only consider the gene g (g = 1,. . .,G) in sample j (j = 1,. . .,n)
where G is the total number of genes and n is the total number of samples. Let Ygj be the num-
ber of observed reads mapped to a gene g for sample j, Nj be the total number of mapped reads
for all genes in sample j, N be the total number of mapped reads across all samples, N be the
mean of the reads across all samples, ugj be the true and unknown expression level and Lg be
the length of the specific gene g.











In this study, we examine eight existing and two proposed normalization methods with
detailed statistical notations as described in S1 Appendix.
Like microarray data analysis, the raw read counts of RNA-seq data are first preprocessed
to remove all zero read counts across conditions before the normalization procedure. Thus, in
the case of a balanced sample size design, genes with total raw read counts across conditions
less than the number of sample replicates are filtered out. For data with an unbalanced sample
size design, the gene with an average number of raw reads across conditions less than one are
filtered out. In addition, a value of 0.1 is added to the raw counts for those genes to avoid zero
read counts that are used for the following normalization as well as the other normalization
methods. Our proposed methods include two steps described as follows:
Step 1: Median and Quantile normalization. a. Median (Med) [23]. Let YMedgj be the
median-normalized reads of gene g in sample j. Median normalization is based on all constitu-
tive gene reads with positive counts for all samples. For each sample j, the normalization factor
q50j is the median (50
th percentile or 2nd quartile) of the mapped reads of the genes in each sam-
ple after filtering out the genes with zero read counts across samples [18]. The observed Ygj is
scaled by q50j per average of median reads across all samples ð NmedÞ. Y
Med








b. Upper Quartile (UQ) [18]. If the majority of genes have very low read counts in a RNA-
seq experiment, upper-quartile normalization is preferred to median normalization (50th per-
centile) [18]. Let YUQgj be upper-quartile-normalized reads of gene g in sample j. Upper-quartile
normalization is based on all constitutive gene reads with positive counts for all samples. For
each sample j, the normalization factor q75j is the upper-quartile (75
th percentile) of the mapped
reads of the genes in the sample after filtering out the genes with zero read counts across sam-
ples. The observed Ygj is scaled by q75j per average of upper-quartile reads across all samples
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 4 / 22








A study in evaluation of statistical methods for normalization in RNA-seq experiments [18]
demonstrated that upper-quartile normalization reduced bias in the estimation of DEGs rela-
tive to qRT-PCR without noticeably increasing the level of variability as compared to TC
normalization.
Step 2: Per-gene normalization after per-sample global scaling (Med-pgQ2 and UQ-
pgQ2) as follows. a. Med-pgQ2: let YMedgj be the expression value for gene g in sample j scaled
by the median (Med) in Eq (1); let Q2Medg be the median of gene g across samples after median
normalization per sample. Thus, the new normalized counts YMed  pgQ2gj per gene and per 100





b. UQ-pgQ2: let YUQgj be the expression value for gene g in sample j and normalized by UQ
(75%) in Eq (2); let Q2UQg be the median of gene g across samples after UQ normalization.





The multiplication of 100 reads is used for per-gene normalization, similarly approaching
as RPKM and FPKM normalizations in which the normalized reads are obtained via multipli-
cation of one million of reads after being scaled by the length of a transcript per kilobase and
the total read counts per-sample.
Statistical model and the exact test
A study by Robinson et al. [37] demonstrated that the exact test is the best method when the
sample size is small, and results in achieving the nominal FDR compared to other methods
such as the Wald test, the Likelihood Ratio test (LRT) and the asymptotic normal score test. In
order to compare these normalization methods, we chose a negative binomial distribution to
model and the exact test to identify DEGs for the majority of the methods using edgeR. The
detailed descriptions are available in S1 Appendix: Statistical model and the exact test.
The negative binomial (NB) distribution. Briefly, Y * NB(u,ф) is a random variable to
model the observed read counts in RNA-seq data, where Y has mean u and dispersion ф. Its
probability mass function (pmf), the expected value and the variance of Y are correspondingly:
fY yju;фð Þ ¼ PðY ¼ yÞ ¼











EðYÞ ¼ u and VarðY Þ ¼ uþ u2ф: ð5Þ
The above NB model utilizes the conventional parameterization called “NB2” [38]. The dis-
persion parameter ф in Eq (5) measures the extra variance of Y that a Poisson (u) distribution
fails to describe. As ф goes to zero (ф!0), the variance of Y converges to u in probability and
RNA-seq normalization methods
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the distribution of f(y) in (5) converges to the Poisson(u) distribution which was shown by
Cameron and Trivedi [39].
Datasets
1. MAQC2 and MAQC3 datasets. MAQC2 contains two RNA-seq datasets from the
Microarray Quality Control Project (MAQC) [40] with two types of biological samples:
human brain reference RNA (hbr) and universal human reference RNA (uhr). The first dataset
consisted of read length of 36bp and was downloaded from the NCBI sequence read archive
(SRA) with ID SRX016359 (hbr) and SRX016367 (uhr) [18]. The second dataset (GEO series
GSE24284) consisted of the 50bp hbr (sample ID: GSM597210) and uhr (sample ID:
GSM597211) RNA samples [41].
GSE49712_HTSeq.txt.gz for MAQC3 raw read counts with five technical replicates in two
biological conditions (UHR and HBR) was downloaded from GEO (GSE49712) [20]. Four
replicate libraries for two conditions were prepared by one person and the remaining library
was prepared by Illumina. A single HiSeq2000 instrument was used for sequencing all the
samples.
2. TaqMan qRT-PCR data. PCR validation of the uhr sample from GSM12638 to
GSM129641 and the hbr sample from GSM129642 to GSM129645 were downloaded from
GEO (series GSE5350). These MAQC data (uhr and hbr) contain a total of 1044 genes assayed
and validated using TaqMan qRT-PCR with 4 technical replicates [18,41]. Thirty-seven of the
1,044 genes were marked with a Flag Detection “A” in all samples and were considered as true
negative (TN) genes. These additional genes were not filtered out as in recent studies of the
MAQC validation datasets [42] and 1028 of the 1044 genes have either a unique Ensembl gene
Identifier (ID) or Entrez gene ID used for further analysis of the true positive and true negative
genes following Bullard et al.’s study [18]. Briefly, a POLR2A-normalized cycle number for
each gene and each condition is called ΔCt. The value xgik of each gene g in replicate i and con-
dition k is obtained via log2(ΔCt)/log2(e). The log2 fold change is defined as the mean difference
of each gene between the hbr and uhr conditions (xg;hbr   xg;uhr), where the uhr is typically
served as a reference. The genes with |log2 FC|2 were considered DEGs and the genes with |
log2 FC|<0.2 were considered as non-DEGs. Among the 1028 genes, 398 genes with 390
unique gene names fall into the true positive (TP) genes and 178 genes with 151 unique gene
names fall into the true negative (TN) genes. The remaining set of genes lie in a region set to
be indeterminate as far as DEG is concerned.
3. Two human breast cancer RNA-seq datasets. Dataset one is used for simulation con-
taining twenty-four normal tissues and 25 early breast neoplasia (EN) on formalin-fixed paraf-
fin-embedded tissue were sequenced at 3’-end enriched RNA-seq libraries [43].The mapped
raw counts of 49 samples with an average of 7 million reads per sample were downloaded from
NCBI GEO (series GSE47462). The dataset two contains 42 human estrogen receptor positive
(ER+) and HER2 negative breast cancer primary tumors and 30 uninvolved breast tissues sam-
ples adjacent to ER+ primary tumors. The RNA-seq raw data files with a sequence read archive
(SRA) were downloaded from NCBI GEO (GSE58135).
4. Simulated data. Simulated data was based on the human breast cancer RNA-seq data-
set one with two conditions: 24 normal tissues and 25 early neoplasia tissues. The simulation
model is similar to the one described in Dillies’s study [23]. Let G be the total number of genes
(G = 15,000), n = 20 be the total number of samples in two conditions (k = A, B), let yigk be the
count for gene g in sample i and condition k with a Poisson distribution: yigk ∽ Pois(λgk). The
parameter λgk is estimated from the mean reads per gene across samples from this human
breast cancer RNA-seq dataset. Under this model, the null hypothesis H0 (λgA = λgB) means the
RNA-seq normalization methods
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expression values of gene g between conditions A and B are not significantly different, and the
alternative hypothesis H1 (λgA 6¼ λgB) means the gene expression values are significantly differ-
ent between the two conditions. Let p0 and p1 be the proportion of genes generated under H0
and H1 among the G genes, respectively. The data is simulated with 15,000 genes and p1 is 10%
corresponding to 1,500 genes. Under H0, the parameter λgA in the gene g of condition A and
the parameter λgB in the gene g of condition B were estimated from the breast cancer raw
counts corresponding to the mean raw counts of each gene (λgA = λgB); while under H1 the
parameters λgA and λgB in the gene g and condition A and B were equal to (1 + α)λgA for 750
downregulated genes and (1 + α)λgB for 750 upregulated genes, respectively, where α is defined
as 0.5 and 1. To assess the impact of non-equivalent library sizes, we multiplied yigk by a size
factor Si per sample of the condition, which is equal to |εi|, where εi * N(1,1). The number of
simulation was chosen as 13 due to the small variation of the AUC values from all the normali-
zation methods per simulation.
Sequence mapping and extraction of gene counts
The MAQC2 RNA-seq libraries with two technical replicates of each sample (uhr and hbr)
and the human ER+ breast cancer dataset two were mapped to the human hg19 reference
genome using tophat2 (v2.0.13) with Bowtie version (2.2.3.0) and the parameter: ‘no-coverage-
search’ [26,31]. For the FPKM normalization method, the aligned RNA-seq reads were assem-
bled according to the Homo_sapiens.GRCh37.74.gtf annotation file and normalized by FPKM
using Cufflinks-Cuffnorm (v2.2.1). For the other normalization methods, the aligned RNA-seq
reads were sorted by samtools (v0.1.19) and the read count matrix for each replicate of the con-
dition was generated using HTSeq-scripts-count (version 2.7) and provided in S1 Datasets. In
addition, for the human ER+ breast cancer dataset, the read counts from two human ER
+ breast cancer samples and one control sample failed to be extracted using HTSeq-script-
count. Therefore, only 40 ER+ breast cancer and 29 control samples were used for this study.
Software packages for detecting DEGs in normalization methods
The normalization methods and the software packages for detecting DEGs between conditions
using MAQC datasets and the human ER+ breast cancer dataset are summarized in Table 1.
Here, we give a brief description of the software packages used for the normalization and sta-
tistical tests in the present work. edgeR (v3.8.6) [25] was used to perform TMM normalization.
It uses the empirical Bayes estimation and the exact test with a negative binomial distribution.
For this study, edgeR was used to detect DEGs for all the seven normalization methods includ-
ing TC, Med, UQ, FQ, TMM, Med-pgQ2 and UQ-pgQ2. DESeq2 [28], a successor to the
Table 1. Summary of normalization methods and software packages on different datasets for DEGs analysis.
Normalization methods Datasets Statistical test Software packages
TC MAQC and simulated data Exact test edgeR(v3.8.6)
Med MAQC and simulated data Exact test edgeR (v3.8.6)
UQ MAQC and simulated data Exact test edgeR (v3.8.6)
FQ MAQC and simulated data Exact test edgeR (v3.8.6)
TMM MAQC and simulated data Exact test edgeR (v3.8.6)
Med-pgQ2 MAQC and simulated data Exact test edgeR (v3.8.6)
UQ-pgQ2 MAQC and simulated data Exact test edgeR (v3.8.6)
DESeq MAQC and simulated data Wald test DESeq2 (v1.6.3)
FPKM MAQC t-test Cufflinks-cuffdiff2 (v2.2.1)
https://doi.org/10.1371/journal.pone.0176185.t001
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DESeq method [27], shows higher sensitivity and precision compared to DESeq package due
to new features using shrinkage estimators for dispersion and fold changes. DESeq2 also offers
a scaling size factor procedure as DESeq to perform normalization which is based on a median
of ratio method. Cufflinks-Cuffnorm (v2.2.1) with a default parameter setting was used to per-
form FPKM normalization. Cufflinks-Cuffdiff2 was used to perform DEGs analysis at both the
transcript and gene level using a beta negative binomial model and the t-test for the fragment
counts [26]. In this study, we used the gene level results for the comparison with the other nor-
malization methods. With the aid of edgeR, we set the normalization methods to “none” and
selected the exact test with a tag-wise dispersion for each gene to perform DEGs analysis for
the normalization methods: TC, Med, UQ, FQ, Med-pgQ2 and UQ-pgQ2. The normalized
MAQC2 data from Med-pgQ2, UQ-pgQ2, DESeq and TMM-edgeR and DEGs analysis from
these methods are also provided in Supporting Information S2 Datasets–S5 Datasets. More-
over, these normalization methods are written in R (v3.1.3) with the source codes available in
S1 File (.R).
The AUC, standard error and z-statistic test for MAQC data
The area under the ROC curve (AUC) was calculated using Algorithm 2 by Fawcett (2006) [44].
The estimated standard error (se) and a two-sample one-sided z-test were computed for each
AUC value in MAQC data using Hanley J.A. et al. method (1982) [45]. Briefly, let A be the area
under ROC curve; s^e and sd be the estimated standard error and standard deviation, respectively;





, where d1 = A × (1 −A) + (na − 1) × (Q1 −A2) + (nn − 1)(Q2 −A2),
Q1 ¼ A
2  A ; Q2 ¼ 2
A2






p and p.value = 1 − Prob(Z
< z). This p-value was used to compare the AUC values between two normalization methods.
The 95% confidence interval estimation of AUC for the simulated data
The 95% CI (confidence interval) for the simulated data was computed based on the normal
approximation, which is defined as CI ¼ A  1:96 sdffiffinp , where n = 13 is the number of simula-
tions, A and sd are the mean and standard deviation of AUC from 13 simulations, respectively.
Results and discussion
In this study, seven different normalization methods were compared to our proposed methods
(Med-pgQ2 and UQ-pgQ2) via the qualitative characteristics of data distributions, intra-con-
dition variation, ROC curve and AUC value as well as PPV, the actual FDR, sensitivity and
specificity given the nominal FDR ( 0.05).
Qualitative characteristics of data distributions
In DEGs analysis, one important assumption of null hypothesis about normalized RNA-seq
data is that the majority of genes are not differentially expressed between conditions. There-
fore, the overall distributions across genes are expected to be similar. Boxplots of non-normal-
ized log2 expression of raw read counts in Fig 1A shows larger distributional difference
between the replicate libraries for MAQC2 data and normalization methods are needed to
make the sample distributions more similar. Although all the normalization methods stabilized
the distributions across two replicates for MAQC2 data, only our methods further can shrink
the gene expression values towards the median per sample (Fig 1A).
RNA-seq normalization methods
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It is important to compare the intra-condition variation among different normalization
methods to prevent over correction. Fig 1B from MAQC2 data illustrates that little difference
of the intra-condition variation is observed between our methods and others (DESeq, TMM,
TC, Med and UQ), which indicates that scaling does not change the coefficient of variation.
Moreover, we observed that FQ and FPKM methods greatly increased the intra-condition var-
iation compared to the un-normalized data and other normalization methods (Fig 1B). This
observation was also reported by Dillies’ study in 2012.
We further analyzed the human ER+ breast cancer RNA-seq dataset with 40 ER+ breast
cancer samples and 29 controls and MAQC3 with five technical replicates. For the human
breast cancer datasets, similar patterns for most of the normalization methods from the box-
plots (S1 and S2 Figs) are observed compared to MAQC2 in Fig 1. However, the intra-condi-
tion variation of the median across replicates for all the methods (S2 Fig) is close to 0.5, which
is much higher than the value below 0.1 for all the methods obtained from the MAQC2 data
(Fig 1B). This is expected because the breast cancer data contain biological replicates. We
found that TC normalization failed in correcting the raw read counts for some of the replicates
with a higher distributional difference within conditional replicates (S1 Fig). The failed TC
normalization was also observed by Dillies’ study in 2012 using mouse miRNA-seq data. Fur-
thermore, we also discovered that the inability of FQ normalization to minimize the intra-con-
dition variation due to the small sample size from MAQC2 was diminished for the human ER
+ breast cancer datasets with the sample size of 29 in control and 40 in ER+ breast cancer sam-
ples (S2 Fig).
For MAQC3 data, the boxplots (S3 Fig) show that sample distributions normalized by all
methods are very similar, which is expected due to technical replicates with very small varia-
tion. These data with less variation after scaling normalization suggest that a further per gene
Fig 1. Comparison of nine normalization methods. (A) Illustrated are boxplots of log2 (counts+1) for
MAQC data with two replicates in two conditions (uhr and hbr). The samples in hbr and uhr conditions are in
green and red, respectively. Med-pgQ2 and UQ-pgQ2 are our proposed methods. (B) Illustrated are boxplots
of the intra-condition coefficient of variation (uhr and hbr), respectively.
https://doi.org/10.1371/journal.pone.0176185.g001
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normalization may not show a great advantage other than shrinking the data toward the
median across samples.
RMSD between qRT-PCR and RNA-seq log2 fold change computed by
each method
To evaluate the accuracy of normalization methods, we used the MAQC2 and qRT-PCR data
to calculate RMSD (root-mean-square-deviation) correlation between the log2 fold changes
generated from statistical tests for each normalization method (Table 1) and the log2 fold
changes from qRT-PCR. Fig 2 illustrates that almost all the normalization methods have good
concordance to match the qRT-PCR data with RMSD accuracy less than 1.6 except Cufflinks-
Cuffdiff2 with a slightly higher RMSD value (1.77).
Analysis of differentially expressed genes evaluated by ROC curves and
AUC values
The ROC curve in Fig 3 is depicted by the relationship between the sensitivity and specificity
rate based on MAQC2 data. The AUC value is calculated in the full range of false positive rate
(0 FPR1). Med-pgQ2 and UQ-pgQ2 achieve slightly higher AUC values compared to the
others, which reflects the overall performance of detection of DEGs by achieving slightly
higher sensitivity and specificity. With a false positive rate 0.10, the ROC cures reveal our
methods perform slightly better. However, with a higher stringent false positive rate cutoff
(< 0.10), the majority of the methods perform similarly. The quantile global normalization
methods including TC, Med, UQ and FQ perform less favorable for this data. The standard
error corresponding to the AUC value was also calculated using the equation from Hanley
et al. in 1982 [45].
In addition, we further compared the AUC value from one of our methods (Med-pgQ2) to
the others using a two-sample one-sided z-test. Table 2 lists the results of the p-values for each
method. The results demonstrate statistically significant evidence that the AUC value in Med-
pgQ2 is slightly larger than every other method except UQ-pgQ2.
Analysis of PPV, actual FDR, sensitivity, specificity, and the number of
true positive and false positive genes
In order to identify the major difference among all the normalization methods for detection of
DEGs in MAQC2 and MAQC3 data, we calculated the number of true positive (TP) genes and
false positive (FP) genes given the nominal FDR 0.05. We also calculated the positive predic-
tive value (PPV), the actual false discovery rate (FDR), sensitivity and specificity for both data-
sets (Table 3). The results from MAQC2 data suggest that Med-pgQ2 and UQ-pgQ2 can
achieve better specificity rate above 85% than other methods. While TMM-edgeR has the high-
est sensitivity rate (96.7%), its specificity rate (35%) is low. The performance of DESeq normal-
ization with the sensitivity and specificity rate at 93.1% and 60.9% correspondingly are
between our methods and TMM. The two proposed methods also achieve the lower actual
FDR (< 0.1) compared to others. However, the results from MAQC3 with small variation in
Table 3 show that all the methods achieve very high sensitivity rate above 98%, but the specific-
ity for all the methods is lower than 42% and the actual FDR is higher than 0.15. The two new
methods for these data perform slightly better in term of sensitivity, specificity and the actual
FDR.
We further analyzed the DEGs detected only by the top performers such as DESeq, TMM
and our methods using different quartile cutoff of mean expression of raw read counts from all
RNA-seq normalization methods
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genes given the nominal FDR 0.05. The results for the actual FDR, sensitivity and specificity
are listed in Table 4. With the quantile cutoff at 75% by keeping the bottom reads in the analy-
sis, the DESeq normalization has slightly better values in term of the actual FDR and specificity
rate than other methods. TMM is least favorable in this case. With the quantile cutoff at 50%,
DESeq outperforms others. With the quantile cutoff at 25%, TMM shows better performance
than others and DESeq is relatively conserved. However, since there are a fewer genes listed as
true positive and true negative genes at the quantile cutoff at 25% in MAQC2 data, this conclu-
sion is not arbitrary. However, Table 4 suggests that our proposed methods (Med-pgQ2 and
UQ-pgQ2) at the 100% quantile can achieve a sensitivity and specificity rate higher than 92%
and 85% with the actual FDR less than 0.06, respectively. This study based on the MAQC2
data suggests our methods can improve specificity rate and the actual FDR for highly expressed
genes. Based on the overall performance, it clearly indicates our methods might be the better
choice for this kind of data.
To address the question of how gene-wise normalization methods (Med-pgQ and UQ-
pgQ2) improve specificity while maintaining good detection power for highly expressed genes,
Fig 2. RMSD (root-mean-square deviation) between the log2 expression fold changes of MAQC2 and
qRT-PCR. Illustrated is the RMSD between the log2 fold changes computed from DEGs based on different
methods and the values computed from qRT-PCR. FPKM (yellow) has the least similarity while DESeq
normalization (brown) has the highest one.
https://doi.org/10.1371/journal.pone.0176185.g002
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we further analyzed gene-wise dispersion estimated after UQ and UQ-pgQ2 normalization
with the aid of edgeR (Supplemental S4 Fig). Subsequently, gene-wise variance was estimated
on the basis of the mean and estimated dispersion assuming a negative binomial distribution.
We examined the coefficient of variation (CV) in two sets of genes based on a cutoff value of
the mean read count (<100 vs.100) from the UQ method. Genes with mean read count<
100 after UQ normalization were considered lowly expressed while the other genes were con-
sidered highly expressed. Supplemental S5 Fig shows that the coefficient of variation for highly
Fig 3. ROC curve and AUC values from MAQC2 data. The ROC curves and AUC values (inset) for
evaluating the performance of the nine normalization methods were computed using MAQC2 with two
conditions (uhr and hbr). Our proposed methods, Med-pgQ2 and UQ-pgQ2 (blue and grey, respectively)
performed slightly better.
https://doi.org/10.1371/journal.pone.0176185.g003
Table 2. A one-sided of z-test on AUC values from Fig 3 comparing Med-pgQ2 to other methods.
UQ-pgQ2 FPKM TMM DESeq FQ TC
z-statistics 0.7554 2.0082 2.0096 2.5826 2.6861 2.7517
p-value* 0.2250 0.0223 0.02224 0.0049 0.0036 0.0030
*p-values were computed using a one-sided of z-statistic test on the AUC values between Med-pgQ2 and one of the other methods listed in Table 2.
https://doi.org/10.1371/journal.pone.0176185.t002
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 12 / 22
expressed genes after gene-wise normalization is increased via increasing the gene-wise disper-
sion and decreasing the per-gene mean read count compared to UQ normalization. This sug-
gests that per gene normalization is more conservative for highly expressed genes, which at
least partially explains our observation of improved specificity for these genes (Table 4). On
the other hand, the coefficient of variation in lowly expressed genes after gene-wise normaliza-
tion is slightly decreased compared to UQ normalization (S4 Fig, bottom). This suggests that
per gene normalization is less conservative for lowly expressed genes explaining our observa-
tion that our gene-wise normalization methods slightly improve sensitivity in this case
(Table 4).
Evaluation of normalization methods for detecting DEGs using different
fold changes
The simulated data with 10 replicates and two conditions with different fold changes were
used to compare our methods (Med-pgQ2 and UQ-pgQ2) based on the ROC curves. A total of
1,500 genes with a fold change (FC) of 1.5 and 2 are considered as true positive genes and the
remaining genes (13,500) are considered as true negative genes. Fig 4A shows that the ROC
curves for a FC of 1.5 in our methods have an average AUC value of 0.945 compared to others
with the AUC value less than 0.924. Fig 4B shows that the ROC curves for a FC of 2 in our
methods have the average AUC values greater than 0.980 compared to others with AUC values
less than 0.969. However, the difference in the ROC curve and AUC values between our meth-
ods and others decreases as the fold change increases.
Table 3. Analysis of DEGs for MAQC2 and MAQC3 given a nominal FDR 0.05.
Datasets Methods # of TP genes # of FP genes Actual FDR PPV SR SPR
MAQC2 DESeq 363 59 .140 .860 .931 .609
TMM 377 97 .204 .797 .967 .358
FQ 377 100 .210 .790 .967 .338
TC, Med & UQ 376 101 .212 .788 .964 .331
Med-pgQ2 362 22 .057 .942 .928 .854
UQ-pgQ2 364 21 .055 .945 .933 .861
MAQC3 DESeq 385 105 .214 .786 .990 .271
TMM 385 98 .203 .797 .990 .319
TC, Med & UQ 384 99 .204 .795 .987 .313
Med-pgQ2 & UQ-pgQ2 387 83 .177 .823 .995 .424
The number of true positive (TP) and the false positive (FP) genes, the actual false discovery rate (FDR), the positive predictive value (PPV), the sensitivity
rate (SR) and specificity rate (SPR).
https://doi.org/10.1371/journal.pone.0176185.t003
Table 4. The actual FDR, sensitivity and specificity rate from MAQC2 data given a nominal FDR 0.05.
Expression quantile cutoff DESeq TMM-edgeR Med-pgQ2 UQ-pgQ2
Actual FDR SR SPR Actual FDR SR SPR Actual FDR SR SPR Actual FDR SR SPR
100%(total) 0.140 0.931 0.609 0.205 0.967 0.358 0.057 0.928 0.854 0.055 0.933 0.861
75% 0.069 0.861 0.806 0.147 0.931 0.516 0.084 0.877 0.758 0.077 0.898 0.774
50% 0.091 0.476 0.926 0.184 0.738 0.740 0.304 0.762 0.482 0.292 0.810 0.482
25% 0.000 0.000 1.000 0.333 0.333 0.917 0.667 0.667 0.333 0.692 0.667 0.250
The sensitivity rate (SR) and specificity rate (SPR) for DEGs analysis by the top methods at the different-quartile cutoffs.
https://doi.org/10.1371/journal.pone.0176185.t004
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Evaluation of normalization methods for detecting DEGs with biological
replicates
We investigated the impact of biological replicates on the performance of normalization meth-
ods. We randomly sampled four and six replicates from each of 13 simulated datasets with 10
replicates used in Fig 4B, respectively. We sampled twice from one of 13 simulated data in Fig
4B yielding a total of 14 simulations. The mean AUC and standard deviation (SD) of each nor-
malization method were calculated using 14 simulations instead of 13 simulations. The results
from each simulation were consistent with a small standard deviation.
As expected, increasing the number of biological replicates yields a higher statistical power
for detection of DEGs (Fig 5). Under the control of a very small false positive rate, the perfor-
mance of all the methods (Med-pgQ2 and UQ-pgQ2) is similar. Fig 5 demonstrates that bio-
logical replicates are very important for RNA-seq data analysis in order to find true biological
difference between conditions. Our normalization methods would be a good choice for achiev-
ing a slightly higher sensitivity rate at the false positive rate cutoff greater than 0.1. However, a
closer examination for FPR cutoff less than 0.1 indicated that when the number of replicates is
smaller (4 instead of 6), the other methods actually perform better than our proposed methods
at a FPR cutoff less than 0.1 (Fig 5A). This suggests that per gene normalization does not
Fig 4. ROC curve and AUC values from the simulated data at a fold-change of 1.5 and 2. Illustrated are
the ROC curves for detecting 1, 500 DEGs (750 up and 750 dow-regulated) using a fold change = 1.5 (A) and
a fold change = 2 (B) with an unequal library size. Calculated AUC values are in the inset. The simulated data,
containing a total of 15,000 genes in two conditions and 10 replicates per condition, was used for evaluating
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perform well for all circumstances. Therefore, caution is needed when choosing an optimal
normalization method by taking into consideration the number of different replicates and
their variation.
Evaluation of Med-pgQ2 and UQ-pgQ2 methods for detecting DEGs in
different multiplication factors (50, 100, 200, 500, 1000 and 1 million)
Like RPKM and FPKM, we chose to use the small multiplication factor of 100 for our proposed
per gene and per 100 normalization for this study. We also chose different multiplication fac-
tors such as 50, 200, 500, 1000 and 1 million to perform per gene normalization. We per-
formed DEGs analysis using Med-pgQ2 and UQ-pgQ2 with these multiplication factors. The
comparison results based on DEGs analysis are shown in S1 Table. We compared the impact
of multiplication factors on PPV, the actual FDR, sensitivity and specificity. The values of
PPV, the actual FDR, a sensitivity and specificity rate with multiplication factor 100 (S1
Table) are more than 94%, less than 0.06, more than 92% and more than 85%, respectively. Lit-
tle difference among them is observed except with the multiplication factor of 50 having a
slightly higher sensitivity rate with a trade-off of a slightly higher actual FDR and a lower speci-
ficity rate. These results suggest that the choice of multiplication factors with a value greater
than or equal to 100 has no difference on DEG analysis results.
Fig 5. ROC curve and AUC values from the simulated data with 4 and 6 replicates in each condition.
Illustrated are the ROC curves and AUC values (inset) in analyzing the impact of biological replicates on the
performance of normalization methods. We used the simulated data with four biological replicates (A) and six
biological replicates (B), which contain 1,500 DEGs with 2 FC difference between two conditions. Our
methods (UQ-pgQ2 and Med-pgQ2) are in cyan and blue, respectively.
https://doi.org/10.1371/journal.pone.0176185.g005
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Limitations
Our study has some limitations. First, the data normalized by med-pgQ2 and UQ-pgQ2 is
restricted for DEGs analysis between groups and not for other purpose such as identifying
highly or lowly expressed genes as well as comparing gene A to gene B expression levels within
a sample due to the potential change of gene order in a sample after normalization. Second, a
simulation data using a Poisson distribution based on real RNA-seq data with additional varia-
tion generated from a normal distribution was used for the DEG analysis. We do acknowledge
that the lack of simulated data based on the NB distribution is a limitation to the study. How-
ever, inclusion of two real data sets (MAQC2 and MAQC3) offsets this limitation to an extent,
and the combination of the simulated and real data provides fairly comprehensive and consis-
tent answers. Finally, on one hand, the exact test was used to identify DEGs implemented by
edgeR. Although it is recommended for DEG analysis of RNA-seq data in two groups with a
small sample size, we think that evaluating the effect of normalization on more complicated
study designs beyond two-group comparisons is a worthwhile and interesting endeavor, and
we may consider this as potential future work. On the other hand, although a t-test is not com-
monly used for testing hypothesis in RNA-seq data, it is used for testing DEGs with small sam-
ple size in the cDNA Microarray data. Therefore, we need to mention here that a t-test is
invariant to linear transformations and thus would be unaffected by the per-gene normaliza-
tion outlined here.
Summary and conclusion
Several studies have previously compared normalization methods (TC, Med, UQ, FQ, DESeq,
TMM, FPKM and RPKM). TC, FPKM, RPKM and FQ are not suggested for use in DEG analy-
sis due to multiple issues such as lowly expressed gene issue for TC, length correction bias for
FPKM and RPKM, and potentially increasing the intra-condition variation by forcing all the
samples to have identical distributions for FQ [18,20,22,23]. One study has reported that UQ
normalization failed to remove excessive variation from some of the samples [33]. DESeq and
TMM-edgeR are in turn the only choices due to better performance compared to other exist-
ing methods. Although DESeq appears relatively conservative compared to TMM-edgeR
method [36,46], a high false-positive rate particularly for highly expressed genes for both meth-
ods has been observed by several studies [34,42].
In this study, we compared two new normalization methods for RNA-seq data analysis
(Med-pgQ2 and UQ-pgQ2) to the seven existing methods (DESeq, TMM-edgeR, FPKM-Cuff-
Diff, TC, Med, UQ and FQ) based on DEG analysis. The purpose of using per-gene normaliza-
tion approach is to remove technical variations using different chips and allow for comparison
between conditions based on similar count levels [47,48]. The results from this study demon-
strate our proposed methods (Med-pgQ2 and UQ-pgQ2) can achieve a slightly higher value of
AUC for both MAQC2 data and the simulated data at the false positive rate of 0.10, which
reflects improving the overall performance with the detection power under the control of the
low FDR compared to other normalization methods. More importantly, the results of DEG
analysis from MAQC2 data with the different quantile cutoff values given a nominal FDR
0.05, demonstrate our methods can decrease the false positive rate for highly expressed genes
with high read counts giving the result of a specificity rate of greater than 85% without loss of a
detection power (> 92%), while the other methods (i.e., DESeq and TMM-edgeR) have a spec-
ificity rate of less than 70%. Our methods may improve the sensitivity and detect more DEGs
for lowly expressed genes with low read counts. However, given the improvement in the sensi-
tivity for low read-count genes, there is a trade-off of a higher false positive rate in this case
compared to DESeq and TMM-edgeR. Furthermore, the overall results from MAQC2 data
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also show the actual FDR from our methods is less than 0.06 while the actual FDR from
DESeq, TMM-edgeR and others are larger than 0.10. This finding is consistent with the report
by Kvam et al. in 2012. In their study they compared DESeq, edgeR, baySeq and TSPM (two-
stage Poisson model) methods via a simulated data and reported the FDR in these methods are
not controlled well and the actual FDR is larger than the observed FDR [34]. Moreover, we dis-
covered DESeq and TMM have better overall performance than TC, Med, UQ and FQ, which
is also consistent with previous studies. In addition, based on the quantile cutoff analysis of
DEGs in MAQC2 data, we observed that DESeq is a good choice for moderately expressed
genes at the quantile cutoff of 75%, but it is too conservative for lowly expressed genes at quan-
tile cutoffs below 50%. However, TMM method seems to have better control of the false posi-
tive rate for the lowly expressed genes. In addition, the simulated study with four replicates
shows that DESeq and TMM-edgeR methods perform better than our methods at the FPR cut-
off less than 0.05. These new findings may give a better idea for the choice of different normali-
zation methods.
There are several specific potential applications of our normalization methods worth men-
tioning. First, our methods may be useful for analyzing microRNA sequencing (miRNA-seq)
data. Since miRNA expression is usually low compared to the mRNA with a ratio range
0.1~1.3% of total RNA in rat and mouse species, and 0.5~9.2% of total RNA in human sam-
ples, the data might be skewed to the low read counts. Therefore, per gene normalization may
increase the sensitivity with a relative better specificity for detection of differentially expressed
miRNAs [49,50]. However, a comparison study of the performance for analyzing miRNA-seq
between our methods and TMM-edgeR is needed to make definitive conclusions. Second, our
methods are more universally applicable than using control-gene normalization in removing
technical variations since it is hard to identify control genes such as housekeeping genes that
remain at the same expression level regardless of the experimental conditions [23]. Third,
given the importance of downstream analysis on RNA-seq data with a choice of normalization
methods, our methods might be useful, particularly in light of emerging single-cell RNA-seq
data and meta-analysis of RNA-seq data which have highly variable properties.
Finally, the simulated data results show that increasing the number of the biological repli-
cates results in higher ROC curves and AUC values corresponding to higher detection power
and lower false positive rate. However, due to the cost of RNA-seq data, the sample size of bio-
logical replicates was not considered by some of the earlier researchers using NGS technolo-
gies. One study by Hansen et al. in 2011 summarized a large number of published RNA-seq
studies with a table showing that most of them had only one or a few biological replicates [51].
The thousands of DEGs identified from these RNA-seq data lack confidence and require fur-
ther validation. Although laboratory qRT-PCR and Western blotting methods can be used to
validate these identified DEGs, it is very tedious and almost impossible to validate several thou-
sand DEGs. Our per gene normalization methods may be useful for combining the single or a
few replicates of RNA-seq data from different experiments with the same conditions to
increase the power for DEGs analysis.
Like many normalization and pre-processing procedures, our methods involve several
choices of constants which we evaluated empirically. Primarily, in the 2nd step of our methods
we chose to scale the median across samples to be per 100 reads instead of per kilobase or per
million reads which was used by RPKM or FPKM. Our justification for this choice of a scaling
constant in S1 Table shows little difference of PPV, the actual FDR, specificity and sensitivity
for multiplication factors 100 from DEGs analysis, and we picked the smallest scaling factor
possible for which this was true. Secondly, a small positive value (such as 0.1 of one read) is
added in all gene counts to avoid undefined fold changes in DEGs due to zero counts possible
in one condition. This ensures no missing value for DEGs analysis and reduces the variability
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at low count values [52]. To study the robustness of results in the analysis of MAQC2 data, we
considered different additive values (0.05, 0.1, 0.15, 0.2, 0.3, 0.4 and 0.5). The results in S2
Table (Supplementary Information) suggest that the FDR and sensitivity rate monotonically
increased and the specificity rate monotonically decreased as increase in the additive values.
Small positive values such as 0.05, 0.10 and 0.20 are recommended as FDR is reasonably main-
tained (less than 10%) with sensitivity and specificity rates of at least 80%. Furthermore, it is
worth mentioning that preprocessing RNA-seq data such as prefiltering zero read counts
across groups or adding a small positive number to all gene read counts is an option in RNA-
seq data analysis. For example, the procedure to prefilter zero read counts may not avoid filter-
ing out the lowly expressed genes which may be of interest by some researchers. Therefore, the
choice of preprocessing the data will vary according to the experimental study.
Taken together, with the regards to all the discussed limitations, we think our proposed
gene-wise normalization methods (Med-pgQ2 and UQ-pgQ2) might be a good choice for the
skewed RNA-seq data with high variation via improving the false positive rate and maintaining
a good detection power for DEGs analysis of RNA-seq data compared to the other normaliza-
tion methods.
Supporting information
S1 Fig. Data distribution from seven normalization methods using human ER+ breast can-
cer datasets.
(PDF)
S2 Fig. The intra-condition coefficient of variation using human ER+ breast cancer data-
sets.
(PDF)
S3 Fig. Data distribution from seven normalization methods using MAQC3 data.
(PDF)
S4 Fig. Mean vs. Dispersion after UQ and UQ-pgQ2 methods using MAQC2 data. Gene-
wise dispersion was estimated after UQ and UQ-pgQ2 normalization with the aid of edgeR.
The top graph displays mean versus gene dispersion for genes with a quantile cutoff value of
mean read count after UQ normalization of 90%, while the bottom graph displays mean ver-
sus gene dispersion for genes with a quantile cutoff value of mean read count after UQ.pgQ2
normalization of 90%.
(PDF)
S5 Fig. Coefficent of variation (CV) after UQ and UQ-pgQ2 methods using MAQC2 data.
The calculated coefficient of variation (CV) after UQ normalization and per-gene (UQ.pgQ2)
normalization, based on the estimated dispersion parameter from edgeR and assuming a nega-
tive binomial distribution. The top graph displays the CV for genes with mean read count after
UQ normalization of 100, while the bottom graph displays the CV for genes with mean read
count<100.
(PDF)
S1 Table. The effect of the multiplication factors on DEGs analysis for Med-pgQ2 and UQ-
pgQ2 given the nominal FDR0.05. The number of true positive (TP) and false positive (FP)
genes, positive predictive value (PPV), the actual false discovery rate (FDR), sensitivity and
specificity for Med-pgQ2 and UQ-pgQ2 methods are computed with a constant multiplication
value (50, 100, 200, 500, 1000 and 1 million) using MAQC2 data. In addition, we also reported
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 18 / 22
the results from DESeq and TMM methods.
(DOCX)
S2 Table. Evaluation of the small positive values added in read counts for Med-pgQ2 and
UQ-pgQ2 given the nominal FDR0.05. The number of true positive (TP) and false positive
(FP) genes, positive predictive value (PPV), the actual false discovery rate (FDR), sensitivity
and specificity for Med-pgQ2 and UQ-pgQ2 methods are computed from the MAQC2 data.
The results are reported for the choice of the small positive values added to the read counts
(0.05, 0.1, 0.15, 0.20, 0.30, 0.40 and 0.50).
(DOCX)
S1 Appendix. Description of six existing normalization methods, statistical modeling and
the exact test.
(DOCX)
S1 File. The source codes in R script for the different normalization methods.
(R)
S1 Datasets. MAQC2 raw read counts. Raw read count maqc2 data with 2 replicates in 2 con-
ditions extracted from mapping files using Python command line This data contain 36451
genes and the genes with zero counts in both conditions are filtered out.
(ZIP)
S2 Datasets. DEGs analysis of Med-pgQ2-normalized MAQC2 data using edgeR package.
Med-pgQ2-normalized MAQC2 data using our R codes are included.
(ZIP)
S3 Datasets. DEGs analysis of UQ-pgQ2-normalized MAQC2 data using edgeR package.
UQ-pgQ2-normalized MAQC2 data using our R codes are included.
(ZIP)
S4 Datasets. DEGs analysis of DESeq-normalized MAQC2 data using DESeq2 package.
DESeq-normalized MAQC2 data using DESeq package are included.
(ZIP)
S5 Datasets. DEGs analysis of TMM-normalized MAQC2 data using edgeR package.
TMM-normalized MAQC2 data using edgeR package are included.
(ZIP)
Acknowledgments
We would like to thank Dr. Eric Rouchka and Dr. Nigel Cooper who provided the server and
resource for analyzing the large RNA-seq data. This work is part of a doctoral dissertation orig-
inally written by the first author under the supervision of Dr. Shesh Rai and Dr. Guy Brock.
Author Contributions
Conceptualization: XL GB ER DW LO SR.
Data curation: XL AE.
Formal analysis: XL.
Methodology: XL SR GB.
Resources: ER NC.
RNA-seq normalization methods




Writing – original draft: XL.
Writing – review & editing: XL ER GB TO NC RG DW.
References
1. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, et al. (2008) Alternative isoform regula-
tion in human tissue transcriptomes. Nature 456: 470–476. https://doi.org/10.1038/nature07509 PMID:
18978772
2. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity
in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413–1415. https://doi.org/
10.1038/ng.259 PMID: 18978789
3. Schliebner I, Becher R, Hempel M, Deising HB, Horbach R (2014) New gene models and alternative
splicing in the maize pathogen Colletotrichum graminicola revealed by RNA-Seq analysis. BMC Geno-
mics 15: 842. https://doi.org/10.1186/1471-2164-15-842 PMID: 25281481
4. Robertson G, Schein J, Chiu R, Corbett R, Field M, Jackman SD, et al. (2010) De novo assembly and
analysis of RNA-seq data. Nat Methods 7: 909–912. https://doi.org/10.1038/nmeth.1517 PMID:
20935650
5. Schulz MH, Zerbino DR, Vingron M, Birney E (2012) Oases: robust de novo RNA-seq assembly across
the dynamic range of expression levels. Bioinformatics 28: 1086–1092. https://doi.org/10.1093/
bioinformatics/bts094 PMID: 22368243
6. Wu P, Zhang H, Lin W, Hao Y, Ren L, Zhang C, et al. (2014) Discovery of novel genes and gene iso-
forms by integrating transcriptomic and proteomic profiling from mouse liver. J Proteome Res 13:
2409–2419. https://doi.org/10.1021/pr4012206 PMID: 24717071
7. Canovas A, Rincon G, Islas-Trejo A, Wickramasinghe S, Medrano JF (2010) SNP discovery in the
bovine milk transcriptome using RNA-Seq technology. Mamm Genome 21: 592–598. https://doi.org/
10.1007/s00335-010-9297-z PMID: 21057797
8. Djari A, Esquerre D, Weiss B, Martins F, Meersseman C, Boussaha M, et al. (2013) Gene-based single
nucleotide polymorphism discovery in bovine muscle using next-generation transcriptomic sequencing.
BMC Genomics 14: 307. https://doi.org/10.1186/1471-2164-14-307 PMID: 23651547
9. Piskol R, Ramaswami G, Li JB (2013) Reliable identification of genomic variants from RNA-seq data.
Am J Hum Genet 93: 641–651. https://doi.org/10.1016/j.ajhg.2013.08.008 PMID: 24075185
10. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev
Genet 10: 57–63. https://doi.org/10.1038/nrg2484 PMID: 19015660
11. Marguerat S, Bahler J (2010) RNA-seq: from technology to biology. Cell Mol Life Sci 67: 569–579.
https://doi.org/10.1007/s00018-009-0180-6 PMID: 19859660
12. Voelkerding KV, Dames SA, Durtschi JD (2009) Next-generation sequencing: from basic research to
diagnostics. Clin Chem 55: 641–658. https://doi.org/10.1373/clinchem.2008.112789 PMID: 19246620
13. Chrystoja CC, Diamandis EP (2014) Whole genome sequencing as a diagnostic test: challenges and
opportunities. Clin Chem 60: 724–733. https://doi.org/10.1373/clinchem.2013.209213 PMID:
24227285
14. Zeng W, Mortazavi A (2012) Technical considerations for functional sequencing assays. Nat Immunol
13: 802–807. https://doi.org/10.1038/ni.2407 PMID: 22910383
15. Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of
transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14: R36. https://
doi.org/10.1186/gb-2013-14-4-r36 PMID: 23618408
16. Park T, Yi SG, Kang SH, Lee S, Lee YS, Simon R (2003) Evaluation of normalization methods for micro-
array data. BMC Bioinformatics 4: 33. https://doi.org/10.1186/1471-2105-4-33 PMID: 12950995
17. Quackenbush J (2002) Microarray data normalization and transformation. Nat Genet 32 Suppl: 496–
501. https://doi.org/10.1038/ng1032 PMID: 12454644
18. Bullard JH, Purdom E, Hansen KD, Dudoit S (2010) Evaluation of statistical methods for normalization
and differential expression in mRNA-Seq experiments. BMC Bioinformatics 11: 94. https://doi.org/10.
1186/1471-2105-11-94 PMID: 20167110
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 20 / 22
19. Robinson MD, Oshlack A (2010) A scaling normalization method for differential expression analysis of
RNA-seq data. Genome Biol 11: R25. https://doi.org/10.1186/gb-2010-11-3-r25 PMID: 20196867
20. Rapaport F, Khanin R, Liang Y, Pirun M, Krek A, Zumbo P, et al. (2013) Comprehensive evaluation of
differential gene expression analysis methods for RNA-seq data. Genome Biol 14: R95. https://doi.org/
10.1186/gb-2013-14-9-r95 PMID: 24020486
21. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods 5: 621–628. https://doi.org/10.1038/nmeth.1226 PMID:
18516045
22. Oshlack A, Wakefield MJ (2009) Transcript length bias in RNA-seq data confounds systems biology.
Biol Direct 4: 14. https://doi.org/10.1186/1745-6150-4-14 PMID: 19371405
23. Dillies MA, Rau A, Aubert J, Hennequet-Antier C, Jeanmougin M, Servant N, et al. (2013) A comprehen-
sive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis.
Brief Bioinform 14: 671–683. https://doi.org/10.1093/bib/bbs046 PMID: 22988256
24. Risso D, Schwartz K, Sherlock G, Dudoit S (2011) GC-content normalization for RNA-Seq data. BMC
Bioinformatics 12: 480. https://doi.org/10.1186/1471-2105-12-480 PMID: 22177264
25. Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expres-
sion analysis of digital gene expression data. Bioinformatics 26: 139–140. https://doi.org/10.1093/
bioinformatics/btp616 PMID: 19910308
26. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L (2013) Differential analysis of
gene regulation at transcript resolution with RNA-seq. Nat Biotechnol 31: 46–53. https://doi.org/10.
1038/nbt.2450 PMID: 23222703
27. Anders S, Huber W (2010) Differential expression analysis for sequence count data. Genome Biol 11:
R106. https://doi.org/10.1186/gb-2010-11-10-r106 PMID: 20979621
28. Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq
data with DESeq2. Genome Biol 15: 550. https://doi.org/10.1186/s13059-014-0550-8 PMID: 25516281
29. Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in
microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
30. Bengtsson H, Neuvial P, Speed TP (2010) TumorBoost: normalization of allele-specific tumor copy
numbers from a single pair of tumor-normal genotyping microarrays. BMC Bioinformatics 11: 245.
https://doi.org/10.1186/1471-2105-11-245 PMID: 20462408
31. Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ, et al. (2010) Transcript assem-
bly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell dif-
ferentiation. Nat Biotechnol 28: 511–515. https://doi.org/10.1038/nbt.1621 PMID: 20436464
32. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. (2012) Differential gene and transcript
expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7: 562–578.
https://doi.org/10.1038/nprot.2012.016 PMID: 22383036
33. Risso D, Ngai J, Speed TP, Dudoit S (2014) Normalization of RNA-seq data using factor analysis of
control genes or samples. Nat Biotechnol 32: 896–902. https://doi.org/10.1038/nbt.2931 PMID:
25150836
34. Kvam VM, Liu P, Si Y (2012) A comparison of statistical methods for detecting differentially expressed
genes from RNA-seq data. Am J Bot 99: 248–256. https://doi.org/10.3732/ajb.1100340 PMID:
22268221
35. Seyednasrollah F, Laiho A, Elo LL (2013) Comparison of software packages for detecting differential
expression in RNA-seq studies. Brief Bioinform.
36. Soneson C, Delorenzi M (2013) A comparison of methods for differential expression analysis of RNA-
seq data. BMC Bioinformatics 14: 91. https://doi.org/10.1186/1471-2105-14-91 PMID: 23497356
37. Robinson MD, Smyth GK (2008) Small-sample estimation of negative binomial dispersion, with applica-
tions to SAGE data. Biostatistics 9: 321–332. https://doi.org/10.1093/biostatistics/kxm030 PMID:
17728317
38. Mi G, Di Y, Schafer DW (2015) Goodness-of-fit tests and model diagnostics for negative binomial
regression of RNA sequencing data. PLoS One 10: e0119254. https://doi.org/10.1371/journal.pone.
0119254 PMID: 25787144
39. Cameron AC, Trivedi PK (1998) Regression analysis of count data. Cambridge University Press: 566.
40. Consortium M, Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, et al. (2006) The MicroArray Qual-
ity Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measure-
ments. Nat Biotechnol 24: 1151–1161. https://doi.org/10.1038/nbt1239 PMID: 16964229
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 21 / 22
41. Wan L, Sun F (2012) CEDER: accurate detection of differentially expressed genes by combining signifi-
cance of exons using RNA-Seq. IEEE/ACM Trans Comput Biol Bioinform 9: 1281–1292. https://doi.
org/10.1109/TCBB.2012.83 PMID: 22641709
42. Zhang ZH, Jhaveri DJ, Marshall VM, Bauer DC, Edson J, Narayanan RK, et al. (2014) A comparative
study of techniques for differential expression analysis on RNA-Seq data. PLoS One 9: e103207.
https://doi.org/10.1371/journal.pone.0103207 PMID: 25119138
43. Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, et al. (2014) A shared transcriptional program
in early breast neoplasias despite genetic and clinical distinctions. Genome Biol 15: R71. https://doi.
org/10.1186/gb-2014-15-5-r71 PMID: 24887547
44. Fawcett T (2006) An introduction to ROC analysis. Pattern Recognition Letters 27: 861–874.
45. Hanley JA, McNeil BJ (1982) The Meaning and Use of the Area under a Receiver Operating Character-
istic (ROC) Curve. Radiology 143: 29–36. https://doi.org/10.1148/radiology.143.1.7063747 PMID:
7063747
46. Seyednasrollah F, Laiho A, Elo LL (2015) Comparison of software packages for detecting differential
expression in RNA-seq studies. Brief Bioinform 16: 59–70. https://doi.org/10.1093/bib/bbt086 PMID:
24300110
47. Ness SA (2006) Basic microarray analysis: strategies for successful experiments. Methods Mol Biol
316: 13–33. https://doi.org/10.1385/1-59259-964-8:13 PMID: 16671398
48. Smyth GK, Speed T (2003) Normalization of cDNA microarray data. Methods 31: 265–273. PMID:
14597310
49. Becker C, Hammerle-Fickinger A, Riedmaier I, Pfaffl MW (2010) mRNA and microRNA quality control
for RT-qPCR analysis. Methods 50: 237–243. https://doi.org/10.1016/j.ymeth.2010.01.010 PMID:
20079844
50. Walleshauser JG III, Kessler T, Morse D, Tannous BA, Chiu NHL (2012) A Simple Approach for Evalu-
ating Total MicroRNA Extraction from Mouse brain Tissues. Journal of Analytical Sciences, Methods
and Instrumentation 2: 5–12.
51. Hansen KD, Wu Z, Irizarry RA, Leek JT (2011) Sequencing technology does not eliminate biological
variability. Nat Biotechnol 29: 572–573. https://doi.org/10.1038/nbt.1910 PMID: 21747377
52. Law CW, Chen Y, Shi W, Smyth GK (2014) voom: Precision weights unlock linear model analysis tools
for RNA-seq read counts. Genome Biol 15: R29. https://doi.org/10.1186/gb-2014-15-2-r29 PMID:
24485249
RNA-seq normalization methods
PLOS ONE | https://doi.org/10.1371/journal.pone.0176185 May 1, 2017 22 / 22
